Skip To Main Content
M. Gaibar on Muck Rack

M. Gaibar

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with M.

Contact M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants

|
By A. Villar Novillo, M. Rubió, S. Hernando, AM Martin, R. Khedaoui, JM Rodríguez-Piñas, A. Romero-Lorca, M. Gaibar, B. Antón-Pascual, I. Alemany, FI Camacho, M. Cavanagh, M. Boiza, D. Marrupe, A. Fernández-Santander
| Nature Verified
Abstract The treatment of urothelial cancer (UC) has been revolutionized by the introduction of immune checkpoint inhibitors (ICIs). However, while ICIs have achieved better therapeutic results than traditional chemotherapeutic agents, immune-related adverse events (irAEs) can lead to poor treatment outcomes.
Open in Who Shared Issue with article?
See all 1 articles